Cardiovascular disease is the leading cause of death worldwide and the need for vascular substitutes is constantly increasing due to the low number of healthy donors.

The aim of the I3D-ARTERE is to produce polymer vascular substitute implantable in the human body using additive manufacturing technology, capable of withstanding variations in blood flow pressure, while adapting to the morphology and both mechanical and biological properties of the patient.

SEGULA Technologies, with the help of its partner 3d.Fab, has designed a novel method and custom-made biomaterials. This solution provides the possibility to meet the needs of each patient efficiently and rapidly thanks to the controlled degradation of polymers and simultaneous cellular regrowth.